Searched for
COMBINATION DRUG
AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...11 Jun, 2026, 11.48 AM IST- Hetero partners with Richter to develop, market Semaglutide injection globallyHyderabad's Hetero Labs partners with European giant Gedeon Richter. They will jointly develop and sell Semaglutide Injection, the generic ...10 Jun, 2026, 06.16 PM IST
- Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tabletsConcord Biotech's shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approv...10 Jun, 2026, 01.11 PM IST
- AI saves clinicians time but most lack training, survey findsArtificial intelligence is helping doctors and nurses save time and see more patients. However, a Philips survey shows most healthcare work...09 Jun, 2026, 09.37 PM IST
- India’s quantum opportunity: Turning scale into strategic advantageIndia has a structural advantage in quantum computing. Its size inherently creates challenging optimisation issues, offering a practical te...09 Jun, 2026, 10.19 AM IST
- Intel spinout Articul8 eyes $50 million for India heritage AI ventureArticul8, a spin-off from Intel, is raising $30-50 million to establish an India-based AI entity focused on traditional knowledge systems l...09 Jun, 2026, 06.00 AM IST
- US stocks | Alphabet taps Intel to make three million in-house chips: ReportNvidia has not placed an order with Intel yet, but has been evaluating whether the company's technology can be used to make a processor tha...08 Jun, 2026, 10.02 PM IST
- Intel CEO unveils AI innovations and partnerships at mega tech event in TaiwanIntel unveiled new AI-focused technologies, strategic collaborations, and next-generation processors at Computex 2026. The company announce...04 Jun, 2026, 04.14 PM IST
- In 1937, a chemistry student tasted something sweet on a cigarette, and this led to a sweetener that changed diet foods industryA lab accident in 1937 led to the discovery of cyclamate, an artificial sweetener. It quickly became popular for low-calorie products. Late...03 Jun, 2026, 04.36 PM IST
- Concord Biotech shares jump 8% on USFDA nod for Mycophenolate Mofetil oral suspensionConcord Biotech shares saw a significant jump on Wednesday. This surge followed the company's announcement of receiving approval from the U...03 Jun, 2026, 11.39 AM IST
- Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block dealShares of Alkem Laboratories will be in focus after block deals worth around Rs 930 crore saw 17.88 lakh shares traded at Rs 5,200 apiece o...03 Jun, 2026, 09.07 AM IST
- US IPO: Honeywell Quantinuum targets valuation of over $14 billion. Should you buy?Quantinuum's revised IPO terms comes on the heels of the U.S. government unveiling plans last month to take $2 billion in equity stakes acr...01 Jun, 2026, 07.28 PM IST
- Honeywell's Quantinuum eyes $14.3 billion valuation in upsized US IPOThe Broomfield, Colorado-based company is now seeking up to $1.46 billion by marketing 26.5 million shares priced between $53 and $55 apiec...01 Jun, 2026, 07.07 PM IST
- Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....01 Jun, 2026, 10.11 AM IST
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...01 Jun, 2026, 07.44 AM IST
- Johnson & Johnson prostate cancer drug reduces risk of cancer spread and death in late-stage studyThe study, which followed patients for over five years, found that those who received the regimen were nine times more likely to have lit...31 May, 2026, 05.38 PM IST
- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...31 May, 2026, 05.00 PM IST
Load More
